visit
One of the innovations in the era of Covid that could carry highly promising ramifications for the industry comes in the form of the Patient Status Engine (PSE), which has been developed to automatically collect raw patient data and decision-support tools for clinicians through the use of wearable sensors and wireless networks combined with big data in order to generate high-resolution patient monitoring.
Currently developed for use in two NHS trusts domestically and in other global use cases, it’s a class-2 medical device that’s FDA-approved in America and currently the only end-to-end digital solution of its kind. , CEO and co-founder of Isansys Lifecare, likened the PSE to something of an app store for healthcare:“Bedside equipment in hospitals gives clinically accurate data, but isn’t portable, while wearable products generally don’t provide information accurate enough to make clinical decisions,” Errey explains. “People are developing their own artificial intelligence to run within our platform.”Installed behind hospital firewalls, the PSE works through the use of wireless connections, essentially connecting patients through Android ‘gateways’ running Isansys applications that can receive incoming data from encrypted Bluetooth connections. This can facilitate the development of high-dependency isolation wards where patients can easily be monitored and tended to they produce to be of concern.
The emergence of Covid has prompted healthcare workers to embrace technology at a much faster rate and in a way that’s certainly saved lives and ensured that patients could stay safe at home.The fact that this has been possible for the NHS, a universal healthcare system, shows how quickly large institutions can embrace new technologies within medicine.
Belfast-based artificial intelligence software firm, Axial3D, deployed its 3D capabilities during the pandemic to develop new ways of printing face shields, ventilator parts and nasopharyngeal swabs for testing.
Following clinical trials across the US, the firm sent 100,000s of specially designed swabs to capture Covid samples in North America, Europa and Asia. Measuring at around 15 centimetres, these swabs are produced on Formlabs printers on surgical guide resin to keep samples better intact than traditional swabs. They can also be condensed into tubes, with each printer capable of creating 1,000 per day. , said: “Our primary market has been the US, where demand is huge.” Johnston also noted that demand for these medically optimised supplies aren’t slowing down over time, stating that “there won’t be a turning point backwards.”As the arrival of Covid vaccines around the world paves the way towards an end of a difficult era in human history, the innovations that have emerged within the world of healthcare will begin to be explored worldwide.
In the near future, it’s worth looking out for the various adopted technologies that private health insurance organisations can offer patients , while we can also expect the NHS to continue to build on its e-healthcare offerings through the form of virtual appointments and video consultations. 2021 looks set to bring us the light at the . But even more cause for optimism can be found in the new preventative measures that medical practices can offer patients which have been developed to combat the virus. By building on the strides taken during the pandemic, the future looks increasingly bright for modern healthcare.